2024 annual financial data
TriSalus Life Sciences 2024 Operating cash flow growth
Direct answer
Operating cash flow growth was 18.39%.
Operating income was -36,165,000 USD and net income was -30,045,000 USD.
Operating cash flow was -40,843,000 USD.
Get free TriSalus Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,431,000 USD
- Operating income
- -36,165,000 USD
- Net income
- -30,045,000 USD
- Operating cash flow
- -40,843,000 USD